Oren Gilad
2022
In 2022, Oren Gilad earned a total compensation of $753.2K as President and Chief Executive Officer at Aprea Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $197,252 |
|---|---|
| Option Awards | $121,934 |
| Salary | $323,585 |
| Stock Awards | $110,417 |
| Total | $753,188 |
Gilad received $323.6K in salary, accounting for 43% of the total pay in 2022.
Gilad also received $197.3K in non-equity incentive plan, $121.9K in option awards and $110.4K in stock awards.
Rankings
In 2022, Oren Gilad's compensation ranked 3,633rd out of 5,760 executives tracked by ExecPay. In other words, Gilad earned more than 36.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,633 out of 5,760 | 37th |
Division Manufacturing | 2,067 out of 3,136 | 34th |
Major group Chemicals And Allied Products | 995 out of 1,422 | 30th |
Industry group Drugs | 932 out of 1,323 | 30th |
Industry Pharmaceutical Preparations | 680 out of 969 | 30th |
Source: SEC filing on July 11, 2023.
Gilad's colleagues
We found four more compensation records of executives who worked with Oren Gilad at Aprea Therapeutics in 2022.